This inventor holds 2 USPTO granted patents. Top assignee: Sandoz Gmbh. Active years: 1991-1995.
Company Filing History:
Years Active: 1991-1995
Title: The Innovative Contributions of Stefan Blarer
Introduction
Stefan Blarer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, his work has the potential to impact various medical treatments.
Latest Patents
Blarer's latest patents include an optical isomer of dimethenamid, which relates to a novel method of preparation and herbicidal compositions. This invention focuses on the compound (1S,aRS)-2-chloro-N-(2,4-dimethyl-3-thienyl)-N-(2-methoxy-1-methylethyl)acetamide and its application in combating weeds. Another significant patent involves pharmaceutically useful benzo(b)pyranes and pyranopyridines. These new compounds are designed to treat raised blood pressure, vascular disorders, hair loss, asthma, and other respiratory issues. The compounds also include K+ channel activators, which are beneficial for various therapeutic uses.
Career Highlights
Stefan Blarer is currently associated with Sandoz GmbH, a leading global healthcare company. His work at Sandoz has allowed him to focus on innovative pharmaceutical solutions that address pressing health concerns. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Blarer has collaborated with notable colleagues such as Reynold Chollet and Thomas Vettiger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stefan Blarer's inventive work in pharmaceuticals showcases his commitment to improving health outcomes through innovative solutions. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective treatments.